Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou)
Abstract Background Among the several strategies recommended for the fight against malaria, seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine combination (SPAQ) targets children 3 months to 5 years in Sahel regions of Africa to reduce mortality and mortality. Sinc...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Malaria Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12936-024-05150-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850134515275530240 |
|---|---|
| author | Innocent M. Ali Isaac A. Manga Akindeh M. Nji Valery P. Tchuenkam Peter Thelma Ngwa Neba Dorothy F. Achu Jude D. Bigoga Babacar Faye Cally Roper Colin J. Sutherland Wilfred F. Mbacham |
| author_facet | Innocent M. Ali Isaac A. Manga Akindeh M. Nji Valery P. Tchuenkam Peter Thelma Ngwa Neba Dorothy F. Achu Jude D. Bigoga Babacar Faye Cally Roper Colin J. Sutherland Wilfred F. Mbacham |
| author_sort | Innocent M. Ali |
| collection | DOAJ |
| description | Abstract Background Among the several strategies recommended for the fight against malaria, seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine combination (SPAQ) targets children 3 months to 5 years in Sahel regions of Africa to reduce mortality and mortality. Since SMC with SPAQ is administered to symptoms-free children for prevention of malaria, it is anticipated that a proportion of asymptomatic parasitaemic children will also be treated and may result in a drop in both the overall population prevalence of asymptomatic malaria infections, subsequent risk of symptomatic malaria infections and transmission. Age-specific carriage of asymptomatic Plasmodium spp. infections (API) was evaluated in target children and adults in Cameroon and Senegal, prior to the 2018 SMC campaign in both countries. Methods A baseline household survey was carried out in August 2018 in two areas in Cameroon and one in Senegal just before the beginning of distribution of SPAQ for SMC. The survey included collection of fingerpick blood for malaria rapid diagnostic testing (RDT) and administration of a pre-tested questionnaire on demographics and malaria risk factors to participants. The age-specific prevalence of API in all study sites was analysed, first as a distribution of RDT-positives in 5-year age categories and secondly, with age as a continuous variable in the whole sample, using the Wilcoxon rank sum test. Risk factors for carriage of asymptomatic infections were examined using logistic regression analysis in STATA v.16 and Rv4.1.2. Results In total, 6098 participants were surveyed. In Cameroon, overall prevalence of API was 34.0% (32.1–36.0%) in Adamaoua, and 43.5% (41.0–45.7%) in the North. The median age of RDT positivity was higher in Senegal: 11 years (IQR 7–16) than in Cameroon—Adamaoua: 8 years (4–17) and North: 8 years (4–12) and significantly different between the three study regions. In all three study sites, asymptomatic carriage was significantly higher in the older age group (5–10 in Cameroon, and 7–14 in Senegal), compared to the younger age group, although the median age of participants was lower among RDT-negatives in the North compared to RDT-positives. Health area, gender and last infection within past year significantly confounded the relationship between age and parasite carriage in Adamaoua and Senegal but not in North Cameroon. Absence of bed net and previous infection within one month of the survey all independently predicted carriage of asymptomatic parasites in multivariate regression analysis. Conclusion Under five years asymptomatic Plasmodium infection in northern Cameroon prior to SMC season remained high in 2018, irrespective of history of SMC implementation in the study areas in Cameroon. Compared to Adamaoua, peak asymptomatic malaria parasite rate was observed in children 5–10 years, which is out of the SMC target age-range. Health area, last infection within the past month and to a lesser extent gender affected the association between age and asymptomatic carriage in all sites except the North region of Cameroon, indicating wide heterogeneity in risk of malaria among the general population in that geography. Follow-up studies designed to measure SMC effects in Cameroon are warranted as it may become necessary to extend age of SMC eligibility to 10 years, as is practiced in Senegal. |
| format | Article |
| id | doaj-art-a89759d974aa4c869e6e6292b0aafe69 |
| institution | OA Journals |
| issn | 1475-2875 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | BMC |
| record_format | Article |
| series | Malaria Journal |
| spelling | doaj-art-a89759d974aa4c869e6e6292b0aafe692025-08-20T02:31:41ZengBMCMalaria Journal1475-28752024-12-0123111610.1186/s12936-024-05150-3Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou)Innocent M. Ali0Isaac A. Manga1Akindeh M. Nji2Valery P. Tchuenkam3Peter Thelma Ngwa Neba4Dorothy F. Achu5Jude D. Bigoga6Babacar Faye7Cally Roper8Colin J. Sutherland9Wilfred F. Mbacham10MARCAD Programme, The Biotechnology Centre, University of Yaoundé 1Department of Parasitology and Mycology, Faculty of Medicine and Odontostomatology, Université Cheick Anta DiopMARCAD Programme, The Biotechnology Centre, University of Yaoundé 1Department of Biochemistry, University of DschangMARCAD Programme, The Biotechnology Centre, University of Yaoundé 1National Malaria Control Programme, Ministry of Public HealthMARCAD Programme, The Biotechnology Centre, University of Yaoundé 1Department of Parasitology and Mycology, Faculty of Medicine and Odontostomatology, Université Cheick Anta DiopDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical MedicineDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical MedicineMARCAD Programme, The Biotechnology Centre, University of Yaoundé 1Abstract Background Among the several strategies recommended for the fight against malaria, seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine combination (SPAQ) targets children 3 months to 5 years in Sahel regions of Africa to reduce mortality and mortality. Since SMC with SPAQ is administered to symptoms-free children for prevention of malaria, it is anticipated that a proportion of asymptomatic parasitaemic children will also be treated and may result in a drop in both the overall population prevalence of asymptomatic malaria infections, subsequent risk of symptomatic malaria infections and transmission. Age-specific carriage of asymptomatic Plasmodium spp. infections (API) was evaluated in target children and adults in Cameroon and Senegal, prior to the 2018 SMC campaign in both countries. Methods A baseline household survey was carried out in August 2018 in two areas in Cameroon and one in Senegal just before the beginning of distribution of SPAQ for SMC. The survey included collection of fingerpick blood for malaria rapid diagnostic testing (RDT) and administration of a pre-tested questionnaire on demographics and malaria risk factors to participants. The age-specific prevalence of API in all study sites was analysed, first as a distribution of RDT-positives in 5-year age categories and secondly, with age as a continuous variable in the whole sample, using the Wilcoxon rank sum test. Risk factors for carriage of asymptomatic infections were examined using logistic regression analysis in STATA v.16 and Rv4.1.2. Results In total, 6098 participants were surveyed. In Cameroon, overall prevalence of API was 34.0% (32.1–36.0%) in Adamaoua, and 43.5% (41.0–45.7%) in the North. The median age of RDT positivity was higher in Senegal: 11 years (IQR 7–16) than in Cameroon—Adamaoua: 8 years (4–17) and North: 8 years (4–12) and significantly different between the three study regions. In all three study sites, asymptomatic carriage was significantly higher in the older age group (5–10 in Cameroon, and 7–14 in Senegal), compared to the younger age group, although the median age of participants was lower among RDT-negatives in the North compared to RDT-positives. Health area, gender and last infection within past year significantly confounded the relationship between age and parasite carriage in Adamaoua and Senegal but not in North Cameroon. Absence of bed net and previous infection within one month of the survey all independently predicted carriage of asymptomatic parasites in multivariate regression analysis. Conclusion Under five years asymptomatic Plasmodium infection in northern Cameroon prior to SMC season remained high in 2018, irrespective of history of SMC implementation in the study areas in Cameroon. Compared to Adamaoua, peak asymptomatic malaria parasite rate was observed in children 5–10 years, which is out of the SMC target age-range. Health area, last infection within the past month and to a lesser extent gender affected the association between age and asymptomatic carriage in all sites except the North region of Cameroon, indicating wide heterogeneity in risk of malaria among the general population in that geography. Follow-up studies designed to measure SMC effects in Cameroon are warranted as it may become necessary to extend age of SMC eligibility to 10 years, as is practiced in Senegal.https://doi.org/10.1186/s12936-024-05150-3Seasonal malaria chemopreventionAsymptomatic malariaAdamaouaKedougouPlasmodium |
| spellingShingle | Innocent M. Ali Isaac A. Manga Akindeh M. Nji Valery P. Tchuenkam Peter Thelma Ngwa Neba Dorothy F. Achu Jude D. Bigoga Babacar Faye Cally Roper Colin J. Sutherland Wilfred F. Mbacham Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou) Malaria Journal Seasonal malaria chemoprevention Asymptomatic malaria Adamaoua Kedougou Plasmodium |
| title | Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou) |
| title_full | Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou) |
| title_fullStr | Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou) |
| title_full_unstemmed | Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou) |
| title_short | Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou) |
| title_sort | asymptomatic plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in northern cameroon and south senegal kedougou |
| topic | Seasonal malaria chemoprevention Asymptomatic malaria Adamaoua Kedougou Plasmodium |
| url | https://doi.org/10.1186/s12936-024-05150-3 |
| work_keys_str_mv | AT innocentmali asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT isaacamanga asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT akindehmnji asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT valeryptchuenkam asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT peterthelmangwaneba asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT dorothyfachu asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT judedbigoga asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT babacarfaye asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT callyroper asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT colinjsutherland asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou AT wilfredfmbacham asymptomaticplasmodiumfalciparuminfectionsanddeterminantsofcarriageinaseasonalmalariachemopreventionsettinginnortherncameroonandsouthsenegalkedougou |